|
|
Previous Article | Table of Contents | Next Article 
Recombinant human stem cell factor enhances the formation of colonies by
CD34+ and CD34+lin- cells, and the generation of colony-forming cell
progeny from CD34+lin- cells cultured with interleukin-3, granulocyte
colony-stimulating factor, or granulocyte-macrophage colony-stimulating
factor
ID Bernstein, RG Andrews and KM Zsebo
Program in Pediatric Oncology, Fred Hutchinson Cancer Research Center,
Seattle, WA 98104.
We tested the ability of recombinant human stem cell factor (SCF) to
stimulate isolated marrow precursor cells to form colonies in semisolid
media and to generate colony-forming cells (CFC) in liquid culture. SCF, in
combination with interleukin-3 (IL-3), granulocyte-macrophage
colony-stimulating factor (GM-CSF), or granulocyte colony-stimulating
factor (G-CSF) caused CD34+ cells to form increased numbers of
granulocyte-macrophage colonies (CFU-GM), and to form macroscopic erythroid
burst-forming units (BFU-E) in the presence of IL-3, erythropoietin (Epo),
and SCF. We tested isolated CD34+lin- cells, a minor subset of CD34+ cells
that did not display antigens associated with lymphoid or myeloid lineages,
and CD34+lin+ cells, which contain the vast majority of CFC, and found that
the enhanced colony growth was most dramatic within the CD34+lin-
population. CD34+lin- cells cultured in liquid medium containing SCF
combined with IL-3, GM-CSF, or G-CSF gave rise to increased numbers of CFC.
Maximal numbers of CFU-GM were generated from CD34+lin- cells after 7 to 21
days of culture, and required the presence of SCF from the initiation of
liquid culture. The addition of SCF to IL-3 and/or G-CSF in cultures of
single CD34+lin- cells resulted in increased numbers of CFC due to the
proliferation of otherwise quiescent precursors and an increase in the
numbers of CFC generated from individual precursors. These studies
demonstrate the potent synergistic interaction between SCF and other
hematopoietic growth factors on a highly immature population of CD34+lin-
precursor cells.
Volume 77,
Issue 11,
pp. 2316-2321,
06/01/1991
Copyright © 1991 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Simon, E. Dondi, A. Chaix, P. de Sepulveda, T. J. Kubiseski, N. Varin-Blank, and L. Velazquez
Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells
Blood,
November 15, 2008;
112(10):
4039 - 4047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Wang, H. Hisha, S. Taketani, M. Inaba, Q. Li, W. Cui, C. Song, T. Fan, Y. Cui, K. Guo, et al.
Neural Cell Adhesion Molecule Contributes to Hemopoiesis-Supporting Capacity of Stromal Cell Lines
Stem Cells,
September 1, 2005;
23(9):
1389 - 1399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Chen, R. P. Revoltella, S. Papini, M. Michelini, W. Fitzgerald, J. Zimmerberg, and L. Margolis
Multilineage Differentiation of Rhesus Monkey Embryonic Stem Cells in Three-Dimensional Culture Systems
Stem Cells,
May 1, 2003;
21(3):
281 - 295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Velazquez, A. M. Cheng, H. E. Fleming, C. Furlonger, S. Vesely, A. Bernstein, C. J. Paige, and T. Pawson
Cytokine Signaling and Hematopoietic Homeostasis Are Disrupted in Lnk-deficient Mice
J. Exp. Med.,
June 17, 2002;
195(12):
1599 - 1611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-M. Huang, C.-J. Huang, and J. J.-Y. Yen
Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways
Blood,
September 1, 2000;
96(5):
1764 - 1771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. DiPersio, M. W. Schuster, C. N. Abboud, J. N. Winter, V. R. Santos, D. M. Collins, J. W. Sherman, and C. M. Baum
Mobilization of Peripheral-Blood Stem Cells by Concurrent Administration of Daniplestim and Granulocyte Colony-Stimulating Factor in Patients With Breast Cancer or Lymphoma
J. Clin. Oncol.,
July 14, 2000;
18(14):
2762 - 2771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ueda, H. Yoshino, K. Kobayashi, M. Kawahata, Y. Ebihara, M. Ito, S. Asano, T. Nakahata, and K. Tsuji
Hematopoietic Repopulating Ability of Cord Blood CD34+ Cells in NOD/Shi-scid Mice
Stem Cells,
May 1, 2000;
18(3):
204 - 213.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Ikehara
Pluripotent Hemopoietic Stem Cells in Mice and Humans
Experimental Biology and Medicine,
February 1, 2000;
223(2):
149 - 155.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Huss
Isolation of Primary and Immortalized CD34- Hematopoietic and Mesenchymal Stem Cells from Various Sources
Stem Cells,
January 1, 2000;
18(1):
1 - 9.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. A. Vallera, S.-Y. Seo, A. Panoskaltsis-Mortari, J. D. Griffin, and B. R. Blazar
Targeting myeloid leukemia with a DT390-mIL-3 fusion immunotoxin: ex vivo and in vivo studies in mice
Protein Eng. Des. Sel.,
September 1, 1999;
12(9):
779 - 785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Facon, J.-L. Harousseau, F. Maloisel, M. Attal, J. Odriozola, A. Alegre, W. Schroyens, C. Hulin, R. Schots, P. Marin, et al.
Stem Cell Factor in Combination With Filgrastim After Chemotherapy Improves Peripheral Blood Progenitor Cell Yield and Reduces Apheresis Requirements in Multiple Myeloma Patients: A Randomized, Controlled Trial
Blood,
August 15, 1999;
94(4):
1218 - 1225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ricotti, F. Fagioli, E. Garelli, C. Linari, N. Crescenzio, A. L. Horenstein, P. Pistamiglio, S. Vai, M. Berger, L. C. diMontezemolo, et al.
c-kit Is Expressed in Soft Tissue Sarcoma of Neuroectodermic Origin and Its Ligand Prevents Apoptosis of Neoplastic Cells
Blood,
April 1, 1998;
91(7):
2397 - 2405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kimura, H. Sakabe, S. Tanimukai, T. Abe, Y. Urata, K. Yasukawa, A. Okano, T. Taga, H. Sugiyama, T. Kishimoto, et al.
Simultaneous Activation of Signals Through gp130, c-kit, and Interleukin-3 Receptor Promotes a Trilineage Blood Cell Production in the Absence of Terminally Acting Lineage-Specific Factors
Blood,
December 15, 1997;
90(12):
4767 - 4778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sogo, M. Inaba, H. Ogata, H. Hisha, Y. Adachi, S.-i. Mori, J. Toki, K. Yamanishi, H. Kanzaki, M. Adachi, et al.
Induction of c-kit Molecules on Human CD34+/c-kit
Stem Cells,
November 1, 1997;
15(6):
420 - 429.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C.G. Begley, R. Basser, R. Mansfield, B. Thomson, W.R.L. Parker, J. Layton, B. To, J. Cebon, W.P. Sheridan, R.M. Fox, et al.
Enhanced Levels and Enhanced Clonogenic Capacity of Blood Progenitor Cells Following Administration of Stem Cell Factor Plus Granulocyte Colony-Stimulating Factor to Humans
Blood,
November 1, 1997;
90(9):
3378 - 3389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Guerriero, L. Worford, H. K. Holland, G.-R. Guo, K. Sheehan, and E. K. Waller
Thrombopoietin Is Synthesized by Bone Marrow Stromal Cells
Blood,
November 1, 1997;
90(9):
3444 - 3455.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.A. Glaspy, E.J. Shpall, C.F. LeMaistre, R.A. Briddell, D.M. Menchaca, S.A. Turner, M. Lill, L. Chap, R. Jones, M.D. Wiers, et al.
Peripheral Blood Progenitor Cell Mobilization Using Stem Cell Factor in Combination With Filgrastim in Breast Cancer Patients
Blood,
October 15, 1997;
90(8):
2939 - 2951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. N. Haylock, M. J. Horsfall, T. L. Dowse, H. S. Ramshaw, S. Niutta, S. Protopsaltis, L. Peng, C. Burrell, I. Rappold, H.-J. Buhring, et al.
Increased Recruitment of Hematopoietic Progenitor Cells Underlies the Ex Vivo Expansion Potential of FLT3 Ligand
Blood,
September 15, 1997;
90(6):
2260 - 2272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Maekawa, T. A. Takahashi, M. Fujihara, N. Urushibara, E. Kadowaki-Kikuchi, M. Nishikawa, K. Ikebuchi, S. Asano, K. Ozawa, and S. Sekiguchi
A Novel Gene (drad-1) Expressed in Hematopoiesis-Supporting Stromal Cell Lines, ST2, PA6 and A54 Preadipocytes: Use of mRNA Differential Display
Stem Cells,
September 1, 1997;
15(5):
334 - 339.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Bhatia, D. Bonnet, U. Kapp, J. C.Y. Wang, B. Murdoch, and J. E. Dick
Quantitative Analysis Reveals Expansion of Human Hematopoietic Repopulating Cells After Short-term Ex Vivo Culture
J. Exp. Med.,
August 18, 1997;
186(4):
619 - 624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. C. Broudy
Stem Cell Factor and Hematopoiesis
Blood,
August 15, 1997;
90(4):
1345 - 1364.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sakatoku and S. Inoue
In Vitro Proliferation and Differentiation of Erythroid Progenitors of Cord Blood
Stem Cells,
July 1, 1997;
15(4):
268 - 274.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Cesana, C. Carlo-Stella, L. Mangoni, E. Regazzi, D. Garau, G. Sammarelli, C. Caramatti, C. Almici, and V. Rizzoli
In Vitro Growth of Mobilized Peripheral Blood Progenitor Cells is Significantly Enhanced by Stem Cell Factor
Stem Cells,
May 1, 1997;
15(3):
207 - 213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. Moskowitz, P. Stiff, M. S. Gordon, I. McNiece, A. D. Ho, J. J. Costa, E. R. Broun, R. A. Bayer, M. Wyres, J. Hill, et al.
Recombinant Methionyl Human Stem Cell Factor and Filgrastim for Peripheral Blood Progenitor Cell Mobilization and Transplantation in Non-Hodgkin's Lymphoma Patients --- Results of a Phase I/II Trial
Blood,
May 1, 1997;
89(9):
3136 - 3147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. McKinstry, C.-L. Li, J. E.J. Rasko, N. A. Nicola, G. R. Johnson, and D. Metcalf
Cytokine Receptor Expression on Hematopoietic Stem and Progenitor Cells
Blood,
January 1, 1997;
89(1):
65 - 71.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Goff, D. Shields, B. Petersen, V. Zajac, G. Michalopoulos, and J. Greenberger
Synergistic effects of hepatocyte growth factor on human cord blood CD34+ progenitor cells are the result of c-met receptor expression
Stem Cells,
September 1, 1996;
14(5):
592 - 602.
[Abstract]
|
 |
|
|
|